Trial 4P-11-4


Multi-Dimensional Assessment of Circulating Tumor Cells in Patients Treated For Metastatic Prostate Cancer.

Type: Other
Phase: Not Applicable
Status: Open to Accrual
Treatments:
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Mitchell Gross, M.D.
Other Trial Staff:  Lagrimas Ilagan, D.M., Olga Castellanos, Coordinator, Taison Tran, Coordinator, Honorina Enright, D.M., Yvette Viverette, R.N., Brandi Scott, Coordinator, Patrick Gilmore, Coordinator

Staff may log in to see study documents.


You may participate in this study if:
 Requirement
1Men with metastatic prostate ca about to begin a systemic therapy involving androgen-deprivation therapy or docetaxel
2At least 18 years of age
3No signs or symptoms of active infection
4Willing to comply with experimental procedures
5Signed an approved study-specific informed consent and HIPAA





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.